The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Celgene
Honoraria - CTI; Roche Pharma AG
Consulting or Advisory Role - Gilead Sciences; Takeda
Research Funding - Roche Pharma AG (Inst)
Expert Testimony - CTI; Takeda
 
Honoraria - RIEMSER; Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
 
Research Funding - Roche Pharma AG (Inst)
Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial.
 
Norbert Schmitz
No Relationships to Disclose
 
Maike Nickelsen
No Relationships to Disclose
 
Bettina Altmann
No Relationships to Disclose
 
Marita Ziepert
No Relationships to Disclose
 
Kamal Bouabdallah
No Relationships to Disclose
 
Christian Gisselbrecht
No Relationships to Disclose
 
S?bastien Maury
No Relationships to Disclose
 
Guillaume Cartron
No Relationships to Disclose
 
Emmanuel Gyan
No Relationships to Disclose
 
Arnaud Jaccard
No Relationships to Disclose
 
Laurence Sanhes
No Relationships to Disclose
 
Philippe Gaulard
No Relationships to Disclose
 
Andreas Rosenwald
No Relationships to Disclose
 
Lorenz Truemper
No Relationships to Disclose
 
Bertram Glass
Honoraria - MSD; RIEMSER; Roche Pharma AG
 
Peter Reimer
No Relationships to Disclose
 
Wolfgang Herr
No Relationships to Disclose
 
Martin Wilhelm
No Relationships to Disclose
 
Olivier Tournilhac
Research Funding - Fresenius Biotech (Inst); Pierre Fabre (Inst)